Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard
- PMID: 25287103
- PMCID: PMC4187456
- DOI: 10.1136/bmjopen-2014-005096
Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard
Abstract
Objective: To evaluate the reference values for short-term heart rate variability (HRV), estimate the performance of cardiovascular autonomic neuropathy (CAN) diagnostic tests in the absence of a gold standard, and assess CAN prevalence in our dataset.
Setting: Community and hospital health centre.
Participants: Of 2092 subjects available for data analysis, 371 healthy subjects were selected so the reference values for the short-term HRV test could be evaluated. An external dataset contained 88 subjects who completed both the short-term HRV test and Ewing's test.
Intervention: Collection of information on clinical outcome.
Primary and second outcome measures: Cardiovascular autonomic function evaluated by using the short-term HRV test and/or Ewing's test.
Results: Cut-off points of 356.13, 55.45 and 36.64 ms2 were set for total power, low frequency and high frequency (HF), respectively. The diagnostic test for CAN based on the mentioned reference value was created. The HRV test had a high sensitivity (80.01-85.09%) and specificity (82.30-85.20%) for CAN. In addition, the non-inferiority test rejected the null hypothesis that the performance of the HRV test was inferior to that of Ewing's test (p<0.05). The estimated CAN prevalence was 14.92% and 29.17% in the total sample and patients with diabetes, respectively.
Conclusions: Our findings provided reference values for short-term HRV, which were used for the CAN diagnostic test with high sensitivity and specificity. The estimated CAN prevalence was high in the Chinese population.
Keywords: EPIDEMIOLOGY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures

Similar articles
-
Diagnostic performance analysis for diabetic cardiovascular autonomic neuropathy based on short-term heart rate variability using Bayesian methods: preliminary analysis.Diabetol Metab Syndr. 2015 Sep 10;7:74. doi: 10.1186/s13098-015-0070-z. eCollection 2015. Diabetol Metab Syndr. 2015. PMID: 26366204 Free PMC article.
-
Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people.J Endocrinol Invest. 2014 Apr;37(4):385-91. doi: 10.1007/s40618-013-0047-4. Epub 2014 Jan 9. J Endocrinol Invest. 2014. PMID: 24633734
-
Can coefficient of variation of time-domain analysis be valuable for detecting cardiovascular autonomic neuropathy in young patients with type 1 diabetes: a case control study.BMC Cardiovasc Disord. 2017 Jan 19;17(1):34. doi: 10.1186/s12872-016-0467-0. BMC Cardiovasc Disord. 2017. PMID: 28103812 Free PMC article.
-
[Heart rate variability in evaluation of the autonomic nervous system. A review].Ugeskr Laeger. 1997 Nov 3;159(45):6666-71. Ugeskr Laeger. 1997. PMID: 9411980 Review. Danish.
-
Diabetic autonomic neuropathy.Diabetes Care. 2003 May;26(5):1553-79. doi: 10.2337/diacare.26.5.1553. Diabetes Care. 2003. PMID: 12716821 Review.
Cited by
-
Prevalence and heart rate variability characteristics of premature ventricular contractions detected by 24-hour Holter among outpatients with palpitations in China: a cross-sectional study.BMJ Open. 2022 Aug 2;12(8):e059337. doi: 10.1136/bmjopen-2021-059337. BMJ Open. 2022. PMID: 35918118 Free PMC article.
-
The analysis of blood pressure profiles and their severity in relation to diabetic cardiovascular autonomic neuropathy in the Chinese population: preliminary analysis.J Endocrinol Invest. 2016 Aug;39(8):891-8. doi: 10.1007/s40618-016-0444-6. Epub 2016 Mar 3. J Endocrinol Invest. 2016. PMID: 26940214
-
Systematic Review on HRV Reference Values.J Cardiovasc Dev Dis. 2025 Jun 6;12(6):214. doi: 10.3390/jcdd12060214. J Cardiovasc Dev Dis. 2025. PMID: 40558649 Free PMC article. Review.
-
Erratum to: Diagnostic performance analysis for diabetic cardiovascular autonomic neuropathy based on short-term heart rate variability using Bayesian methods: preliminary analysis.Diabetol Metab Syndr. 2017 Feb 16;9:14. doi: 10.1186/s13098-017-0213-5. eCollection 2017. Diabetol Metab Syndr. 2017. PMID: 28239423 Free PMC article.
-
The association and interaction analysis of metabolic syndrome and chronic kidney disease on cardiovascular autonomic neuropathy in the general Chinese population.Int J Clin Exp Med. 2015 Jun 15;8(6):9649-57. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26309639 Free PMC article.
References
-
- Hazari MA, Khan RT, Reddy BR, et al. . Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population. Neurosciences (Riyadh) 2012;17:173–5 - PubMed
-
- Spallone V, Ziegler D, Freeman R, et al; on behalf of the Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011. doi:10.1002/dmrr.1239 [Epub ahead of print 22 Jun 2011]. - PubMed
-
- Iodice V, Low DA, Vichayanrat E, et al. . Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences. J Neurol Sci 2011;310:133–8 - PubMed
-
- Ewing DJ, Martyn CN, Young RJ, et al. . The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491–8 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous